Patents by Inventor Aranza Barreda ABARCA

Aranza Barreda ABARCA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Lapatinib particles and uses thereof
    Patent number: 12029818
    Abstract: The disclosure provides particles of at least 95% by weight of lapatinib, or a pharmaceutically acceptable salt thereof, wherein the particles have a specific surface area (SSA) of at least 10 m2/g and have a mean particle size by volume distribution of between about 0.7 ?m and about 8 ?m.
    Type: Grant
    Filed: July 14, 2022
    Date of Patent: July 9, 2024
    Assignee: CRITITECH, INC.
    Inventors: Jacob Sittenauer, Joseph Farthing, Mark Williams, Michael Baltezor, Gere Dizerega, Aranza Barreda Abarca, Shelby Clark
  • CISPLATIN PARTICLES AND USES THEREOF
    Publication number: 20240216424
    Abstract: Compositions of particles having at least 95% by weight of cisplatin and a specific surface area (8SA) of at least 3.5 m2/g. methods for their use. and methods for their production are provided.
    Type: Application
    Filed: April 25, 2022
    Publication date: July 4, 2024
    Inventors: Jacob SITTENAUER, Aranza Barreda ABARCA, Joseph FARTHING, Mark WILLIAMS, Michael BALTEZOR
  • NICLOSAMIDE PARTICLES AND USES THEREOF
    Publication number: 20230414510
    Abstract: The disclosure provides compositions and methods for use of compositions that include particles comprising at least 30% niclosamide by weight, or a pharmaceutically acceptable salt, hydrate, or solvate thereof, wherein the particles have one or more of: (i) a mean bulk density (not tapped) of less than 0.40 g/cm3; 00 a mean tapped density of less than 0.55 g/cm 3 ; and/or (in) a specific surface area (SSA) of at least 3.6 m2/g.
    Type: Application
    Filed: September 8, 2021
    Publication date: December 28, 2023
    Inventors: Michael BALTEZOR, Jacob SITTENAUER, Joseph FARTHING, Mark WILLIAMS, Aranza Barreda ABARCA
  • Sorafenib particles and uses thereof
    Publication number: 20230364021
    Abstract: Particles of at least 95% by weight of sorafenib, or a pharmaceutically acceptable salt thereof are provided, wherein the particles have a specific surface area (SSA) of at least 2 m2/g and have a mean particle size by volume distribution of between about 0.7 ?m and about 8 ?m, as are methods for their use, and methods for making such particles.
    Type: Application
    Filed: July 18, 2023
    Publication date: November 16, 2023
    Inventors: Jacob SITTENAUER, Joseph FARTHING, Mark WILLIAMS, Michael BALTEZOR, Gere DIZEREGA, Aranza Barreda ABARCA, Shelby CLARK
  • Rucaparib particles and uses thereof
    Patent number: 11738029
    Abstract: Compositions of particles having at least 95% by weight of rucaparib and a specific surface area (SSA) of at least 12 m2/g, methods for their use, and methods for their production are provided.
    Type: Grant
    Filed: November 8, 2022
    Date of Patent: August 29, 2023
    Assignee: CRITITECH, INC.
    Inventors: Jacob Sittenauer, Aranza Barreda Abarca, Shelby Clark, Joseph Farthing, Mark Williams, Gere Dizerega, Michael Baltezor
  • Niraparib particles and uses thereof
    Patent number: 11738014
    Abstract: Compositions of particles having at least 95% by weight of niraparib and a specific surface area (SSA) of at least 5 m2/g, methods for their use, and methods for their production are provided.
    Type: Grant
    Filed: November 8, 2022
    Date of Patent: August 29, 2023
    Assignee: Crititech, Inc.
    Inventors: Jacob Sittenauer, Aranza Barreda Abarca, Shelby Clark, Joseph Farthing, Mark Williams, Gere Dizerega, Michael Baltezor
  • Rucaparib particles and uses thereof
    Publication number: 20230142186
    Abstract: Compositions of particles having at least 95% by weight of rucaparib and a specific surface area (SSA) of at least 12 m2/g, methods for their use, and methods for their production are provided.
    Type: Application
    Filed: November 8, 2022
    Publication date: May 11, 2023
    Inventors: Jacob SITTENAUER, Aranza Barreda ABARCA, Shelby CLARK, Joseph FARTHING, Mark WILLIAMS, Gere DIZEREGA, Michael BALTEZOR
  • Niraparib particles and uses thereof
    Publication number: 20230142591
    Abstract: Compositions of particles having at least 95% by weight of niraparib and a specific surface area (SSA) of at least 5 m2/g, methods for their use, and methods for their production are provided.
    Type: Application
    Filed: November 8, 2022
    Publication date: May 11, 2023
    Inventors: Jacob SITTENAUER, Aranza Barreda ABARCA, Shelby CLARK, Joseph FARTHING, Mark WILLIAMS, Gere DIZEREGA, Michael BALTEZOR
  • Lapatinib particles and uses thereof
    Publication number: 20220370355
    Abstract: The disclosure provides particles of at least 95% by weight of lapatinib, or a pharmaceutically acceptable salt thereof, wherein the particles have a specific surface area (SSA) of at least 10 m2/g and have a mean particle size by volume distribution of between about 0.7 ?m and about 8 ?m.
    Type: Application
    Filed: July 14, 2022
    Publication date: November 24, 2022
    Inventors: Jacob SITTENAUER, Joseph FARTHING, Mark WILLIAMS, Michael BALTEZOR, Gere DIZEREGA, Aranza Barreda ABARCA, Shelby CLARK
  • Sorafenib particles and uses thereof
    Publication number: 20220241257
    Abstract: The disclosure provides particles of at least 95% by weight of sorafenib, or a pharmaceutically acceptable salt thereof, wherein the particles have a specific surface area (SSA) of at least 2 m2/g and have a mean particle size by volume distribution of between about 0.7 ?m and about 8 ?m, methods for their use, and methods for making such particles.
    Type: Application
    Filed: July 21, 2021
    Publication date: August 4, 2022
    Inventors: Jacob SITTENAUER, Joseph FARTHING, Mark WILLIAMS, Michael BALTEZOR, Gere DIZEREGA, Aranza Barreda ABARCA, Shelby CLARK
  • Lapatinib particles and uses thereof
    Publication number: 20220023215
    Abstract: The disclosure provides particles of at least 95% by weight of lapatinib, or a pharmaceutically acceptable salt thereof, wherein the particles have a specific surface area (SSA) of at least 10 m2/g and have a mean particle size by volume distribution of between about 0.7 ?m and about 8 ?m.
    Type: Application
    Filed: July 21, 2021
    Publication date: January 27, 2022
    Inventors: Jacob SITTENAUER, Joseph FARTHING, Mark WILLIAMS, Michael BALTEZOR, Gere DIZEREGA, Aranza Barreda ABARCA, Shelby CLARK